Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcgammaRIIIb and MHC class II expression on the phagocytotic neutrophils.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples